Cure Alzheimer's Fund Cure Alzheimer's Fund

Patient-Based Structural and Functional Biology of Tauopathies

2021

We seek to generate models depicting the unique structures characteristic of abnormal forms of tau protein that accumulate in Alzheimer’s disease and related disorders. In addition, using new structural models, we have generated novel resources to provide both a greater understanding of key events that drive disease, as well as facilitated testing of potential therapies.

Leonard Petrucelli Studies of Tau Translational

Funding to Date

$172,500

Focus

Studies of Tau, Translational

Researchers

Leonard Petrucelli, Ph.D.

Related Content:


Alzheimer’s Disease Tau Consortium: Strain Replication in Mouse and Cell Models Marc Diamond 2024-12-27 Alzheimer’s Disease Tau Consortium: Toxic Consequences of Early Tau Seeding Bradley T. Hyman Rachel Bennett 2024-12-24 Alzheimer’s Disease Tau Consortium: The Role of Amyloid Beta-Induced Membrane Damage in Tau Pathology Katherine Sadleir Robert Vassar 2024-12-23 Alzheimer’s Disease Tau Consortium: Post-Translational Modifications and Tau Ultrastructure; Impact of Amyloid Beta on Tau In Vivo Karen Duff René Frank 2024-12-23 Selective Vulnerability in Posterior Cortical Atrophy John R. Dickson Bradley T. Hyman 2024-11-21 Evaluating the Contribution of TDP-43 Dysfunction and Cryptic Mis-Splicing to Alzheimer’s Disease Pathogenesis Leonard Petrucelli 2024-10-31 Hypertension, Tau, and Neurodegeneration Costantino Iadecola Giuseppe Faraco 2024-06-28 Modulating the Levels of Tau-Seed Interactors to Treat Alzheimer’s Disease Cristian Lasagna-Reeves 2024-05-29